Podcasts about Adherence

Join our Patreon and get access to monthly bonus episodes and more nutriton content!Can fasting really slow aging? Does calorie restriction work for humans, or just for mice and yeast? And how much protein do you actually need to age well? This week on Your Diet Sucks, we break down the evidence behind the most talked-about interventions in the longevity space, what holds up under scrutiny, what doesn't, and why you might not need a supplement stack to live longer, and enjoy life. We dig into:The actual science on calorie restriction, fasting, and supplements—and where the evidence stopsWhat inflammation, oxidative stress, and telomeres have to do with how we ageThe best-researched dietary patterns for living longer (hint: it's not sexy, but it might include red wine)Why protein becomes more important as we ageThe difference between lifespan and healthspan, and why quality of life needs to be part of the conversation

Up to 70% of people with schizophrenia don't take their medication as prescribed. This nonadherence is tied to higher risks of psychosis, relapse, ongoing symptoms, and even suicide attempts. So why do so many people with schizophrenia struggle to stay on their meds — despite such serious consequences? And what can actually be done about it? In this episode of Inside Schizophrenia, host Rachel Star Withers — who lives with schizophrenia — and co-host Gabe Howard explore the complicated reality behind medication adherence. Rachel shares her own experiences with skipping or stopping meds, shedding light on the emotional and psychological challenges that aren't often discussed. They're joined by Dr. Alberto Augsten, a toxicologist and psychopharmacologist who consults with pharmaceutical companies and helps shape best-practice guidelines for psychiatric medications. Dr. Augsten brings expert insight into how treatment can be improved and what steps can be taken to support long-term recovery. Listen now to learn more! Our guest, Dr. Alberto Augsten, is a board certified toxicologist and psychopharmacologist. He is a consultant and expert witness specializing in psychopharmacology and clinical toxicology. Offering professional, impactful, and strategic consulting services, Dr. Augsten caters to legal, healthcare, and clinical practice development. His expertise encompasses many areas, ensuring clients receive top-notch guidance and insights. Dr. Augsten specializes in providing tailored consulting services to assist in the development and optimization of clinical practice standards. His expertise covers many areas crucial for clinic development, allowing for standard of care reviews concerning those matters. Dr. Augsten's influence extends beyond his clinical practice. He offers consultation and education services to pharmaceutical companies, contributing to the advancement of pharmaceutical knowledge and practices. Through his contributions, he is helping to improve patient outcomes and ensure the highest quality of care. Our host, Rachel Star Withers, creates videos documenting her schizophrenia, ways to manage and let others like her know they are not alone and can still live an amazing life. She has written Lil Broken Star: Understanding Schizophrenia for Kids and a tool for schizophrenics, To See in the Dark: Hallucination and Delusion Journal. Fun Fact: She has wrestled alligators. To learn more about Rachel, please visit her website, RachelStarLive.com. Our cohost, Gabe Howard, is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. To learn more about Gabe, please visit his website, gabehoward.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of The Patient From Hell, host Samira Daswani speaks with oncology pharmacist Megan Hartranft about the critical role of oncology pharmacists in cancer care. They discuss the unique responsibilities of oncology pharmacists, the importance of patient education, and the growing field of oral chemotherapy. Megan shares insights on medication adherence, the use of mobile health technologies, and the significance of symptom management in improving patient outcomes. The conversation highlights the need for better integration within healthcare systems and offers practical tips for patients navigating their treatment journey.About Our Guest:Dr. Megan Hartranft is a Clinical Lead with the Clinical and Digital Solutions team, advising on precision oncology products.Prior to joining Labcorp, Dr. Hartranft was a Field Medical Scientific Associate Director at Sanofi, in charge of training for the hematology-oncology medical science liaison team. Earlier as a practicing clinician, she established an oral chemotherapy education program and participated in interprofessional clinics at Rush University Cancer Center. She has also spent time in academia as the oncology faculty member at Rosalind Franklin University of Medicine and Health Sciences, where she maintains an adjunct appointment. Dr. Hartranft is active in several professional organizations, including her roles on the Hematology Oncology Pharmacy Association's Public Policy & Advocacy Committee as well as the American Society of Health System Pharmacy Section of Pharmacy Informatics and Technology Clinical Decision Support and Analytics Advisory Group.BS in Biochemistry/Molecular Biology and BA in Classical Studies - Michigan State University Doctor of Pharmacy - University of North Carolina at Chapel Hill PGY1 Pharmacy Residency - University of Michigan PGY2 Oncology Specialty Residency - University of Georgia/Augusta University Health SystemResources & Links:This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features the PCORI research study here: https://pubmed.ncbi.nlm.nih.gov/30964... ‘Integrating Advance Care Planning Videos into Surgical Oncologic Care: A Randomized Clinical Trial'00:00 Introduction to Oncology Pharmacy02:49 The Role of Oncology Pharmacists in Patient Care06:03 Patient Interaction and Education09:09 Exploring Oral Chemotherapy11:45 Adherence to Oral Anti-Cancer Medications15:01 Mobile Health Technologies in Oncology17:58 Symptom Management and Patient Support21:11 The Future of Oncology Pharmacy24:09 Final Thoughts and Tips for PatientsConnect with Us:Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @mantacares and visit our website at mantacares.com for more episodes and updates.Listen Elsewhere: Website: https://mantacares.com/pages/podcast?... YouTube: https://www.youtube.com/@mantacares Spotify: https://open.spotify.com/episode/3TR1... Apple: https://podcasts.apple.com/us/podcast... Disclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.This episode was supported by an award from the Patient-Centered Outcomes Research Institute.

Send us a textThe Art of Preparedness in a Hair SalonIn this episode, Jen and Todd discuss how preparedness will set your business apart. They touch on the importance of growth opportunities, freedom in the workplace, and the value of supportive mentorship. The episode highlights how using technology and innovative practices can enhance both client and staff experiences. They also share insights on the essential tasks like maintaining cleanliness, conducting real consultations, and the overall importance of creating a welcoming environment. With real-life examples and practical advice, Jen and Todd provide a blueprint for running a successful client and employee-focused salon.00:00 Welcome Back! Catching Up with Jen00:33 Discussing Last Week's Guest: Brooke01:22 Preparedness and Opening Takes02:05 Business Insights: Private Labels and Value Creation05:24 Career Reflections and Personal Growth10:03 Creating a Welcoming Salon Environment13:53 The Importance of Cleanliness and Consistency19:59 Collaboration at Hello Hair Co.20:31 Encouraging Collaboration in the Salon21:17 The Importance of Asking for Help22:01 Adherence to Foundational Principles22:14 Product Selection and Client Satisfaction23:08 Effective Use of Social Media24:53 Small Touches That Make a Big Difference26:09 Leveraging Technology for Client Experience28:42 Creating Growth Opportunities for Staff31:12 Balancing Freedom and Responsibility32:22 Supporting and Mentoring Your Team33:53 Ensuring Proper Equipment and Tools36:14 Marketing, Social Media, and Education37:46 Final Thoughts and ConclusionLinks and Stuff:Our Newsletter Mentoring InquiriesFind more of our things:InstagramHello Hair Pro Website

In today's episode, supported by Azurity Pharmaceuticals, we spoke with Michael J. Mauro, MD, about treatment adherence with nilotinib (Tasigna/Danziten) in patients with Philadelphia chromosome (Ph)–positive chronic myeloid leukemia (CML). Dr Mauro is an attending physician at Memorial Sloan Kettering Cancer Center in New York, New York. In our exclusive interview, Dr Mauro discussed barriers to nilotinib treatment adherence in patients with Ph-positive CML, ways that nonadherence can diminish quality of life and clinical response to treatment, ways that the new formulation of nilotinib addresses adherence issues by reducing the need for fasting, and ongoing research into alternative formulations of other agents that may further improve CML treatment efficacy and tolerability.

What do William Wallace, smart pill bottles, and pharma sales have in common?They all showed up in this week's #TheShot of #DigitalHealth Therapy. Jim Joyce and I had a chat with Innes Meldrum - Scottish-born, New Jersey-rooted CEO of AdhereTech. Innes unpacks his journey from flunking high school to running $Big brands and now cracking one of healthcare's stickiest problems: medication adherence. We covered:

Apply for coaching here Chapters00:00 Hen Do Adventures in Marbella03:00 Reflections on Life and Interesting Encounters05:58 Training Frequency and Muscle Growth08:57 Debunking Fat Loss Myths12:01 Understanding Physiology and Weight Management19:40 The Psychology of Adherence in Dieting22:43 Finding Structure in Flexible Dieting25:08 Navigating Night Shifts and Eating Patterns28:31 Understanding Personal Needs and Boundaries31:44 Protein Timing and Nutritional Strategies33:29 Traveling and Maintaining Dietary Goals36:54 The Privilege of Food Choices and Mindset39:21 Maintaining Muscle on Holiday

Confucius' Analects was my reading this week, accompanied by Chinese traditional music and art. I'll probably be better off for having read it...First, The Analects is a lot like the book of Proverbs in the Bible: aphorism after aphorism, with very little narrative and not much to connect each paragraph. It was truly like drinking from a firehose. That's exactly how I felt this week, trying to get through the book.I did, in fact, try to put together a few cogent thoughts about The Analects itself, ideas I can take forward with me into further reading:The most important virtues for Confucius are courage, wisdom, and Goodness. Goodness is embodied as adherence to type. Whaley's description (from 1938, if that helps) is that it's like calling someone a “true Englishman” as the best compliment. It is attainable by aligning yourself with it rather than chasing it.Ritual is supremely important. Adherence to ritual is necessary to attain the Way of the Good (which is the Ancient, and better way) rather than the Way of Violence (which is the current-day way). Further, respect for parents is a crucial part of ritual.There is a tension between the life of the mind, which is what a gentleman is to develop, and the practical life, which is for common people. Confucius says more than once that a gentleman doesn't pursue practical knowledge but only contemplates ideas.I saw parallels with Stoicism occasionally, and there was some Utopianism, it seems to me. There were also plenty of times when it struck me that Confucius was actually complaining that even though he had great ideas and great teaching, he wasn't getting hired by anyone important.Additionally, I found this podcast about Confucius, by professors at Mount St. Mary's University. A Catholic theologian who likes Confucius was really helpful for this Christian to get a handle on the work.Here's an interesting album of Chinese music.This is a year-long challenge! Join me next week as we tackle two texts from Aristotle.LINKTed Gioia/The Honest Broker's 12-Month Immersive Humanities Course (paywalled!)My Amazon Book List (NOT an affiliate link)CONNECTTo read more of my writing, visit my Substack - https://www.cheryldrury.substack.com.Follow me on Instagram - https://www.instagram.com/cldrury/ LISTENSpotify - https://open.spotify.com/show/5GpySInw1e8IqNQvXow7Lv?si=9ebd5508daa245bdApple Podcasts - https://podcasts.apple.com/us/podcast/crack-the-book/id1749793321 Captivate - https://crackthebook.captivate.fm

In this Huberman Lab Essentials episode, I explore how the nervous system impacts fat loss and how certain behaviors and supplements can accelerate fat burning. I explain how non-exercise movements like fidgeting and shivering trigger adrenaline to boost fat metabolism. I also examine the impact of exercise intensity and fasted workouts on fat burning, and how supplements such as caffeine, GLP-1 and berberine can further support fat loss. These science-based tools go beyond traditional calorie counting to enhance metabolism and improve body composition. Huberman Lab Essentials are short episodes (approximately 30 minutes) focused on essential science and protocol takeaways from past Huberman Lab episodes. Essentials will be released every Thursday, and our full-length episodes will still be released every Monday. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman David: https://davidprotein.com/huberman LMNT: https://drinklmnt.com/huberman Timestamps 00:00:00 Huberman Lab Essentials; Fat Loss 00:01:00 Calories In, Calories Out; Nervous System 00:02:57 Fat Burning, Nervous System & Adrenaline 00:06:31 Sponsor: David 00:07:45 Increase Adrenaline, Shivering, Tool: Fidgeting 00:11:25 Shivering & Fat Loss, White & Brown Fat 00:14:42 Tool: Deliberate Cold Exposure Protocol 00:16:43 Sponsor: AG1 00:18:38 High, Medium vs Low-Intensity Exercise, Exercise Fasted? 00:24:30 Tool: Exercise for Fat Loss; Adrenaline 00:27:18 Sponsor: LMNT 00:28:34 Caffeine, Dose, Exercise & Fat Loss 00:30:17 GLP-1, Yerba Mate, Exercise; Semaglutide 00:33:16 Berberine, Metformin, Insulin 00:34:12 Diet, Adherence, Carbohydrates & Insulin 00:35:52 Recap & Key Takeaways Disclaimer & Disclosures

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency.  Learn how to accelerate your growth by going to outcomesrocket.com Medication nonadherence in older populations is a massive problem that significantly impacts clinical outcomes and healthcare costs.  In this episode, Dr. Chandra Osborn, Chief Experience Officer of AdhereHealth, discusses how her organization improves healthcare delivery by focusing on medication adherence in Medicare Advantage populations. AdhereHealth engages non-adherent members using innovative digital channels and evidence-based behavioral science strategies. Dr. Osborn shares how her personal experience with a chronic condition inspired her dedication to improving medication adherence and addressing social determinants of health like transportation and food insecurity. She explains how the information, motivation, and behavioral skills model guides their approach, ensuring individuals understand the importance of medication, know how to take it, stay motivated, and overcome barriers. Tune in and learn how behavioral science and technology are converging to revolutionize medication adherence! Resources:  Connect and follow Dr. Chandra Osborn on LinkedIn. Learn more about AdhereHealth on their LinkedIn and website. Fast Track Your Business Growth: Outcomes Rocket is a full-service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com

Dr. Centor discusses the evidence that implementation of the SEP-1 Bundle is associated with favorable outcomes for patients with sepsis with Drs. James Ford and Gabriel Wardi.

According to the State of Sales Enablement Report, an estimated 90% of organizations now have enablement functions, representing a 20% year-over-year increase. So with this growth in mind, how can organizations successfully implement an enablement platform that ensures long-term success? Shawnna Sumaoang: Hi, and welcome to the Win-Win podcast. I’m your host, Shawnna Sumaoang. Join us as we dive into changing trends in the workplace and how to navigate them successfully. Here to discuss this topic is Shara Simms, the Director of Global Revenue Enablement at Cloudinary. Thank you for joining us Shara. I’d love for you to tell us a little bit about yourself, your background, and your role. Shara Simms: Thanks for having me. My name’s Shara. I am from the San Francisco Bay area originally moved down to San Diego and never left, married. Two beautiful little girls. I’m the director of Global Revenue Enablement at Cloudinary. The scope of my role is not just the sales teams, but also our customer support teams as well as our partners. So the revenue enablement kind of umbrella hits all of those different teams. And I think something probably really important to call out around the role is when people hear the term enablement, a lot of times they hear or focus on just the training aspect of it. But I think it’s, it’s so much more than that. It’s strategic partnership, it’s sales process, efficiency. It’s the connector between everything going on in the product world and the go-to-market motion and how that information gets filtered down to sales or again, partners or customer support. So that’s a little bit about me and my role. Shawnna Sumaoang: Thank you Shara! We’re glad that you’re here with us. And I couldn’t agree more. I’ve seen the evolution of the enablement profession just absolutely change from kind of being focused on content or focused on training to really taking a strategic seat at the table to help lead the strategy for the organization and how we bring kind of all the go to market motions together. So I love to hear that you’re kind of overseeing that for Cloudinary today, and you have a ton of experience in both sales enablement and leadership roles. I would love for you to talk to us a little bit more about that journey into enablement and how has your approach to sales enablement evolved over the years? Shara Simms: So I actually started out in the finance world working really closely with financial advisors in a customer support manager role. Just supporting day-to-day operations internal systems processes. I was in my, my young twenties, still trying to figure out, you know, what direction I really wanted to take my career. And there was a part of me that had considered going into teaching. I had realized this, this passion that I had for just taking complex situations or overwhelming scenarios and breaking them down into digestible information. And so with that in mind, and while I was working in this support role, an opportunity came up at the same financial company to do some internal training, onboarding for financial advisors, industry best practices, that type of thing. And I think that that was really the first turning point in my career where I realized I can take my business degree and this learned, you know, financial and business literacy and combine it with adult learning. Yeah. So adult learning quickly became not just a job, but really a passion and spent a good amount of my career at this. Finance company going beyond operations and into more marketing and sales type training. From there, I eventually made a jump into tech. I was with ServiceNow for a couple of years, doing a variety of roles from strategy to learning design, and then leading a team of instructional designers and trainers. And then I eventually made the move to Cloudinary and I would say after what has been my career so far that the background of adult learning mixed with the operational and business fluency is really what has served me well. And I think even though I don’t have a background as a seller per se, that’s really the background. The adult learning background and operational and business is what I’ve been able to effectively apply into the world of tech sales and enablement. Shawnna Sumaoang: I love that. I love that operational background that you have. I think it will apply to a lot of what I’d like to talk to you about today. As I mentioned in the introduction,sales enablement is becoming more and more mainstream for a lot of organizations, and those same organizations are trying to figure out, you know, what are the right people, processes, and tools that I need to have in place. Place in order to really do enablement. Right. You know, to your point at that sort of strategic level, and I know that you guys at Cloudinary had been on a previous enablement platform, and moved over to Highspot. I’d love to understand what motivated you to reevaluate and change your enablement tech stack. Shara Simms: So yes, we did move to Highspot a few months ago. I would say there were two really big motivators there for us. The first one, one of the largest ones would be the G Suite interability. There are a lot of platforms out there that have G Suite integration, but Highspot was able to support more of an advanced use case that we had, and the specific example, the previous platform we were on, so they did integrate with Google Drive in the sense that you could make updates to your master Google documents and then those updates would flow through to the version that the sales reps accessed on the platform. I think most platforms can do that, but beyond that basic integration, we had to jump through some hoops to achieve kind of what we really wanted, which was ultimately to take our internal customer data, have that flow through the platform, and then automatically transpose onto our templated customer facing slides for things like account reviews, which saves our CSMs and our account managers just hours of time Highspot can support this, which was really important for us. Whereas the previous platform, we would’ve needed to get virtual machines like parallels, for example, which came at an incremental cost. But more than that, our security team just they weren’t thrilled with that, and it was just extra workaround. So that G Suite Interability was huge in being able to apply our internal data to the slides. And then the, the second big motivator was the administration piece of it. We are a very small team, but a mighty team. But we spent a lot of hours trying to maintain and effectively administrate our previous platform. So the ease of use on Highspot, specifically ease of use with Salesforce integration, that and G Suite was the two big motivators. Shawnna Sumaoang: m. Well I’m glad that you are now a Highspot customer and I think when you make an investment in the right tools for your teams, you wanna make sure that it’s getting adopted and, and they’re able to take full advantage of it. And I know there can be challenges sometimes when rolling out a new enablement platform in driving that adoption, along with maybe, you know, a few other challenges that come along with kind of that change management, what are some of the biggest challenges that you think enablement practitioners might face when they’re rolling out a new enablement platform, and how have you overcome some of those challenges as you prepare to launch? Shara Simms: Yeah. I think first and foremost, the challenge of having a really good and realistic strategy for the rollout and the adoption. I’ll circle back to that thought in just a moment, and the other would be, again, the hurdle of maintenance and administration. It really is time consuming and if you’re a small team without a dedicated resource, it can be challenging. So with that in mind, circling back to my original thought, which was that realistic strategy for rollout and adoption, what we did was recognize, okay, we don’t have a lot of resources here. What is going to be the most impactful thing to our teams and drive, I wouldn’t say drive adoption right out the gate, but drive that initial buy-in and the excitement from our sales teams. We all love our salespeople, but we also know that behavior change and new system adoption can definitely be a challenge. So what’s going to get them excited to where they want to use this platform? For us, we determined it was seeing that Salesforce integration before even getting into building out landing pages and navigation and fancy training curriculums. Just having that Salesforce or whatever, CRM, you may use integration with Highspot so that. The sales individuals can see the recommended content to use right there within their opportunity page. Rolling that out. Got them really excited and bought in and, and it got them asking me on a weekly basis, when are we getting this whole platform? So we took a phased approach, realistic expectations of what we could do within our given resources. Phase one, Salesforce and Highspot integration Phase two, which is where we are right now, Digital Sales Rooms customizing content and sales facing landing pages. We purposely did not want to rush this portion of it because having a really well thought out organization of content on the various landing pages or HighSpot calls ’em spots, we use the term landing page internally. I think that’s probably a really important piece. So that went into our phase two. Then lastly, phase three will be the second half of the year, all of our learning and training curriculums. Shawnna Sumaoang: I love that. I know building strong professional relationships is another key focus of yours. As you implement a new enablement platform, how do you plan to drive adoption and build excitement? As you mentioned, how critical that is just a moment ago for your programs amongst the sales teams that you support. Shara Simms: Yeah, retouching on, you know, the strategy of our phased approach, but beyond that, I think maintaining really close relationships with our sales leaders is very important. It’s something that I do, you know, ensuring that they’re bought in and that we have a measurement of success that the teams will be held to as well is critical. So for example, we’re currently tracking our sales collateral usage. Are the teams using it effectively at the right stages, what’s working, what’s not? And as part of this tracking, we have an agreement with our sales leaders going into phase two of our Highspot rollout. And the agreement is we will be tracking that the teams are using certain pieces of collateral that have been deemed. Essentially a required piece of content to share for all deals. And we’re tracking that. They share it via Highspot. So if they have their own version or own copy of the material that they send directly, we aren’t tracking that. If they didn’t send it through to Highspot, it didn’t happen. And again, the sales leaders are partnering with us to hold their teams accountable. So that kind of strategic relationship at the sales leadership level I think is really important and it’s what’s helped driving our success with adoption of the platform. Shawnna Sumaoang: I love that. As you mentioned in your introduction, shara, you have a lot of experience in training. What are some of your best practices for designing and implementing effective training, and how do you see a new enablement platform optimizing these efforts? Shara Simms: Yeah, so first and foremost, always having clearly defined and stated objectives. This is your North Star. It’s gonna help you define if the. Expectation is a behavior change if it’s truly just knowledge retention, if it’s more so a communication versus training. So without a doubt, I want to call that out as probably the most important thing, and not only stating the objective, but also having really clear alignment and agreement of those objectives with your stakeholders. Beyond that, which was maybe stating the obvious. I think a blended learning approach is always the best tactic to use as well, which is one thing I’m really excited about to build enablement on Highspot with this kind of mixed learning. We’re gonna have the ability to pull in my live webinar schedules combined with any on-demand training courses, then technical product documentation that I need the team to read as part of the overarching curriculum. And it’s all going to be on one platform and one curriculum. We also use a tool called Second Nature, which is like an AI simulation tool for sales. It’s pretty cool. And we can also integrate those AI role plays into the same high spot curriculums. So just the ease of pulling in all of those different types of learning elements into one place. It’s gonna be a really exciting second half of the year for us. I’m also really excited to build out curriculums that are role-based or skill-based. So tying in not only the learning component, but then any collateral or resources from the platform into one place based on the specific role or the specific skill gap that I am ultimately trying to solve for. I think lastly, of course, the measurement component is also key. Being able to get insights that I can actively move against and identify, you know, where do I need to spend more of my time? By rep, by individual rep scorecards. So really, really excited for all of those kind of components and pulling in the best practices of learning. Shawnna Sumaoang: On the topic of insights, as you move forward with the implementation, how do you plan to use data and insights to continue to refine your strategy and really ensure a successful launch? Shara Simms: So I mentioned before that we are tracking collateral usage. Obviously we want to know what reps are using, not using how that correlates back to one or lost deals, but also from a behavioral change perspective. We want to also use that data to help us see how well our reps are following the sales process and where we might need to double down on either reviewing the content because it’s not working or reviewing our actual process because there’s some hurdle in the way for them that we need to solve. There’s also the customer engagement cracking that we’re hoping will help move the needle. So for example, as our reps start using the digital sales rooms, if they share a proposal there and the customer views it, great, there’s an indicator for the rep to follow up, see what questions they may have if the customer doesn’t view a case study that was shared. Okay, follow up with an email, highlight the key points from that case study to ensure the customer sees it. The customer engagement tracking is going to be a really big one that we’re going to to build off of. And then the last thing I’ll say in regards to data is. Specifically sales leaders or the manager’s insights, it’s going to be really important that my team actively works with the sales managers so that they understand, you know, how to read their teams. Data and their team’s insights. Again, I keep talking about behavior change, but really putting a focus on helping the manager turn into an effective coach for their team versus just a manager, right? Manager versus coaching, and really being able to use that data to help their teams get better. So I think those are the three big points. Shawnna Sumaoang: I love that. And, and while we’re on the topic of data, and as you mentioned earlier, you’ve been working on making sure that you have the integration set up between Salesforce. And Highspot, what value do you see in this integration and what outcomes are you hoping to achieve? Shara Simms: Yeah, the Salesforce integration is wonderful. I absolutely love it. We are definitely trying to drive better use of our internal collateral. Not only just using the content, but using the right content at the right stage, and being able to easily track that. Right now it’s very manual for us. Another big piece of this is. Time efficiency. You know, no more searching around to find the piece of collateral that, that a salesperson might need. It’s gonna appear right there in the opportunity for them. And then lastly, selfishly, from an administrative perspective, gaining a lot of time back in maintaining the Salesforce integration already. The integration works seamlessly. I’ve not had. Any trouble versus our, our last platform, we really just never got it to work correctly. Anytime we would update a field name on Salesforce, we would need to manually update the field, you know, in the platform. And that’s just not the case with Highspot. It’s just all in automatic flow. It’s saved us a ton of time. Shawnna Sumaoang: I’m glad to hear that. And as we look ahead, as you look to post-launch, what are some of the key go-to-market initiatives that you’ll be focused on driving? And how will your enablement programs help support these? Shara Simms: Yeah. Our biggest initiative right now that I think is we’re gonna support is the sales process. Adherence the right collateral. Right messaging, right process, all at the right, you know, time and the right stage. This is a mix of the SFDC integration and the landing pages we’re creating in Highspot, which are going to follow more of a sales process versus product-led theme. And what I mean by that is basically being guided by the opportunity situation versus having a seller go in and say, Hey, I just need information on this product. Well, do you really? Or are you jumping straight to solutioning? Where are you right now? Are you in discovery? And you need to pull in this material and have this type of conversation? So it’s really the entire go to market. Sales process that we’re trying to refine and ensure that our sales team is again, following the actions that should be taken versus jumping straight to product or solution material. Shawnna Sumaoang: I love that. This has been fantastic. Shara, last question for you, for our audience, for folks that are looking to roll out a new enablement platform, what’s maybe one piece of advice that you would give them to set them up for success as they get started? Shara Simms: Before you start organizing your content, have a solidified agreement behind the scenes on the methodology for how you want that content to be served up to reps and what content you want to be served up for your reps. It can be really easy to fall into a bottomless pit of content. On a platform, all of the internal resources, all of the FAQs, everything that product or product marketing has ever created, and it contend to get out of hand for reps really quickly. I think it’s fine if you want all of that internal material available, but just have a really smart way that you’re organizing and serving up the content. And I’ll give you our example. So I’m sure there’s, you know, a hundred different ways to do this as a best practice and the way that I do it might not be the best way for you, but again, that’s why we did the SFDC integration first, so that just the key content. Was rolling into the opportunity while we gave ourselves extra time to really think about content organization on our backend and align with product marketing on how we were gonna organize it to be fed out to the teams. Shawnna Sumaoang: I love that. I do think that’s a fantastic tip for our audience. So Shara, thank you again so much for joining us today. I really appreciate it. To our audience, thank you for listening to this episode of the Win-Win podcast. Be sure to tune in next time for more insights on how you can maximize enablement success with Highspot.

Perhaps one of the most important and foundational lectures we've ever done, this talk features a broad overview of Tantrik non-duality in the beginning and then moves on to make a case for a Vedic lifestyle and basic devotion as important foundations for more dramatic, esoteric, non-dual and transgressive practices of Goddess-oriented tantra.We also study the Vedic (and pre-Vedic) roots of Tantra and look at a few of the early schools of our tradition such as the Mīmāmsa, Pāśupata, Lakulīśa, Nyāya & Vaiśeshika to derive from them some grounding ideas for practicing Tantra safely! This lecture was given just after Shiva Ratri and Sri Ramakrishna's birthday and so we attempt to map the historical progression of ideas in Shaivism unto the life of Sri Ramakrishna where we see all these ideas expressed! Books Referenced: 1. Gospel of Sri Ramakrishna by Swami Nikhilananda, a translation of the Kathamrita by M. 2. Sri Ramakrishna and his Divine Play by Swami Chetanananda, a translation of Lilaprasangha by Swami Saradananada3. Sri Ramakrishna and His Disciples by Sister Deva Mata4. Ramakrishna and His Disciples by Christopher Isherwood 5. Sri Ramakrishna: A Prophet For The New Age by Richard Schiffman(if you're new to the literature, I would start with 3., 4. and 5. before moving on to 1. and 2. from the list above) ^You'll find a complete playlist of introductory lectures on Tantra in both theory and practice here. 00:00:00 Meditation on Lord Shiva 00:02:00 Tantrik Non-Duality in a Nutshell 00:08:40 Other Flavors of Tantra and the Progression of the Tradition00:10:36 (a digression on exegesis vs eisegesis) and "doxographical hierarchy"00:13:15 finding the foundations for Tantrik practice & the avatāra (incarnation of God) 00:19:10 our project: mapping the history of Shaivism/Tantra unto the life of Sri Ramakrishna to make a case for finding the foundations for Tantrik practice!00:20:39 The importance of Texts and accountability in teachers00:51:51 Staying Grounded as a Foundation for Esoteric Tantrik Practices 00:55:58 Why this PSA is especially relevant after Shiva Ratri 00:51:12 The importance of Veda and Vedic living, the true foundation of Tantra 01:13:00 Rta, living according to the Rhythm of Nature & Fulfilling the 5 Debts to Rsis, Gods (Forces of Nature), Ancestors, Community and Animals/Plants. 01:14:15 An Aside on Why Swami Vivekananda is Not On My Altar... 01:15:45 Sri Ramakrishna's Adherence to the Veda and Brahminical Codes of Conduct 01:20:02 Shaiva Tantras in the Vedas and "before" the Vedas: the History of our Tradition 01:26:00 Nyāya and Vaiśeshika are early Shaiva Schools! 01:28:50 Why Logic and Thinking Clearly are So Important! (lessons from Nyāya) 01:30:19 The Transgressive Practices of Early Shaivas (Lakulīśa Shaivism) and the Cult of Bhairava as a way of moving beyond the Veda in the name of Devotion! 01:35:45 the Shaiva Siddhānta as the foundation for all Tantra & Puja as the foundational Tantrik Practice Lectures happen live every Monday at 7pm PST and Friday 10am PST and again Friday at 6pm PST.Use this link and I will see you there:https://www.zoom.us/j/7028380815For more videos, guided meditations and instruction and for access to our lecture library, visit me at:https://www.patreon.com/yogawithnishTo get in on the discussion and access various spiritual materials, join our Discord here: https://discord.gg/U8zKP8yMrMSupport the show

Greg Glassman's new venture, MetFix, has generated monster buzz across the fitness industry, and current and former CrossFit affiliate owners are particularly interested. So what exactly is MetFix, and how does it compare to Glassman's other major creation, CrossFit?In this episode of “Run a Profitable Gym,” Two-Brain Business founder Chris Cooper sits down with Glassman's partner in MetFix, Emily Kaplan, to find out.Emily provides the project's background and lays out MetFix's focus on combatting chronic disease through diet and exercise. She explains why the program is designed to complement CrossFit rather than compete with it and offers her perspective on the broader health and fitness landscape.Chris and Emily also discuss how MetFix approaches coaching and education, and they dig into its affiliate model, which many gym owners want to know more about.If you are curious about MetFix, tune in to hear insights directly from one of its founders.  To learn more, visit the MetFix site via the link below.  LinksMetFixGym Owners UnitedBook a Call  00:52 - What is MetFix?17:04 - MetFix certification & affiliates26:08 - Adherence to nutrition plans36:47 - Goal of the affiliate program56:54 - Support for MetFix affiliates

reference: Sri Aurobindo and the Mother, Looking from Within, Chapter 1, Looking at Life and Circumstances, pp.30-31This episode is also available as a blog post at https://sriaurobindostudies.wordpress.com/2025/03/21/the-souls-aspiration-for-adherence-to-the-divine-will-in-manifestation/ Video presentations,interviews and podcast episodes are all available on the YouTube Channel https://www.youtube.com/@santoshkrinsky871More information about Sri Aurobindo can be found at www.aurobindo.net  The US editions and links to e-book editions of SriAurobindo's writings can be found at Lotus Press www.lotuspress.com

Stephen Jones is one of the most well-known trial attorneys currently practicing. With six decades of experience working some of the country's most high-profile Civil Rights cases, he would become a household name after accepting the position of representing Timothy McVeigh in the wake of the Oklahoma City Bombing. In this week's episode, Stephen was kind enough to join me for what I think is best described as a Craft-Conversation around the art of practicing law. So while we talk extensively about his time spent representing McVeigh, if you're looking for your ‘true-crime' fix, this isn't it. We discuss the importance of the Sixth Amendment as a buffer against vengeance, managing the emotional-toll that complex cases take on even the best attorneys, and the often unspoken balancing act between desire for swift justice and need for procedural patience. You don't have to be a lawyer to appreciate the wisdom shared in this episode. But for those who are in the legal profession, I think this is a rare opportunity to listen to, and hopefully learn from, someone who embodies what it means to practice the law in its purest form: absent of ego or prejudice. Enjoy the show. ________________SHOWNOTESBOOK: Other's Unknown by Stephen JonesOKLAHOMA HISTORICAL SOCIETY: Voices of Oklahoma Audio Interviews

Listen Ad Free https://www.solgoodmedia.com - Listen to hundreds of audiobooks, thousands of short stories, and ambient sounds all ad free!

In today's episode, I am breaking down who really gets the faster results- and why focusing on sustainability is way more important. We will chat about dietary adherence, tracking as a temporary tool, and how to build habits you can actually maintain. If you're ready for forever results (not just fast oines), this one is for you!

Listen to learn about dissemination and implementation sciences from our guest Stan Szefler, MD, FAAAAI. Dr. Szefler discusses his work on school-based asthma management programs and key elements in building successful collaborations with the community.Find out more about SA3MPROTMApplying the dissemination and implementation sciences to allergy and immunology: A Work Group Report from the AAAAI Quality, Adherence, and Outcomes Committee

Full article: Use of ChatGPT Large Language Models to Extract Details of Recommendations for Additional Imaging From Free-Text Impressions of Radiology Reports Morgan McLuckey, MD, discusses the AJR article by Li et al. exploring the use of large language models for extracting details related to recommendations for additional imaging from radiology reports.

This podcast explores the intersection of pharmacy and technology, focusing on how machine learning (ML) models are being used to predict medication non-adherence in patients with inflammatory bowel disease (IBD). Dr. Gina Luchen, Director of Digital Health and Data at ASHP and Dr. Christian Rhudy, Associate Director of Quality and Outcomes Research at the University of Kentucky HealthCare discuss Dr. Rhudy's recent ML model research, key findings, and the potential applications of these models across different patient populations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Bec Phillips is a musculoskeletal physiotherapist and educator at Charles Sturt University. In this episode, Bec reflects on her fascinating career in physiotherapy and public health, including her work supporting the health of people in rural Kenya. Bec then explores her PhD research findings and provides practical tips for physiotherapists to help us understand how different types of people adhere to their rehab plans. Thanks, Bec for a great conversation.  You can use the timestamps below to jump to relevant sections and follow the links below to find out more about Bec and her work. In this episode: 0:00 About this episode and welcome Bec 9:11 Improving the health of people in Kenya – problem solving and applying physiotherapy skills on a global scale 22:30 How do you define adherence to rehabilitation? 27:50 What influences adherence in people with Achilles tendinopathy? 30:30 Profiles of people with low, moderate and high adherence. Practical considerations for helping different types of people adhere to their rehab plans 43:45 Collaborating with the patient about their health needs – not a consultancy 44:35 Can you help everyone? 46:40 What factors influence adherence? 56:00 Teaching patients how to build habits if they don't have one. 59:00 Final thoughts Read more about Bec here: https://science-health.csu.edu.au/schools/health-exercise-sports/staff/profiles/physiotherapy/rebecca-phillips Follow Bec on LinkedIn: https://www.linkedin.com/in/rebecca-phillips-b9b361175/?originalSubdomain=au Follow Bec on Instagram @moving_free_physio Read Bec's research: Phillips, R., Hilton, C., Sousa Filho, L. F., Farlie, M., Morrissey, D., & Malliaras, P. (2024). Behaviour change and rehabilitation adherence in adults with tendinopathy: a scoping review. Disability and Rehabilitation, 46(25), 6021-6033. Physio Foundations Podcast Summaries: You can find articles based on Physio Foundations podcast episodes at www.Perraton.Physio or on the Perraton Physio LinkedIn page. Visit our YouTube channel for more: https://www.youtube.com/@PerratonPhysio Follow @PerratonPhysio on Facebook, X (Twitter), Instagram and Linked In. This is a discussion aimed at health professionals and health professional students. Always seek the guidance of a qualified health professional with any questions you may have regarding your health or a medical condition.

Ilana Graetz, PhD, is an Associate Professor at Emory University's Rollins School of Public Health and leader of the Cancer Prevention and Control Research Program at the Winship Cancer Institute. Dr. Graetz's research centers on leveraging health information technology to transform care delivery and improve patient outcomes. As the principal investigator and co-investigator on numerous federally and institutionally funded studies, her work encompasses a wide range of topics, including data analytics, the use of electronic health records and patient portals to enhance care quality and coordination, telehealth innovations, remote monitoring, and patient-reported outcomes. She also leads efforts to design and evaluate mobile health interventions that strengthen patient-provider communication, support treatment adherence, and improve health outcomes.

In this episode, Jame Abraham, MD, FACP; William J. Gradishar, MD, FACP, FASCO; and Laura Spring, MD, review key insights and frequently asked questions related to the CDK4/6 inhibitors used to treat patients with early and metastatic hormone receptor (HR)–positive/HER2-negative breast cancer from a live program held in January 2025. Key clinical pearls include:Adjuvant treatment selection recommendations for patients with HR-positive/HER2-negative early breast cancer based on disease and patient characteristics as well as the latest data and guidelines presented by Dr. GradisharTherapeutic strategies for patients diagnosed with HR-positive/HER2-negative metastatic breast cancer (MBC) presented by Dr. AbrahamAddressing challenges related to CDK4/6 inhibitor adherence and adverse event mitigation presented by Dr. SpringPresenters:Jame Abraham, MD, FACPEnterprise Chair and Professor of MedicineDepartment of Hematology and Medical OncologyCleveland ClinicCleveland, OhioWilliam J. Gradishar, MD, FACP, FASCOBetsy Bramsen Professor of Breast OncologyRobert H. Lurie Comprehensive Cancer CenterNorthwestern UniversityChicago, IllinoisLaura Spring, MDBreast Medical OncologistMass General Hospital Cancer CenterHarvard Medical SchoolBoston, MassachusettsLink to full program including downloadable slides and on-demand webcasts: https://bit.ly/4b5GFqqTo claim credit for listening to this episode, please visit the podcast online at the link above.

Imagine a healthcare solution that not only motivates patients to take charge of their health but also tackles the toughest challenges faced by our most vulnerable communities.In this episode of Straight Out of Health IT, Matthew Swanson, co-founder and CEO of Reciprocity Health, Incorporated, shares insights into how his company is transforming healthcare by combining behavioral health economics and digital tools. Founded in 2020, Reciprocity Health focuses on improving patient activation in Medicaid and Medicare, particularly among vulnerable populations. Their flagship platform, TheraPay, uses financial incentives integrated with digital tools to enhance patient adherence to medical programs. This innovative approach addresses systemic barriers to care, drawing on Swanson's prior experience in education and systemic reform.Reciprocity Health's managed service model was inspired by a CMS study highlighting the effectiveness of financial incentives in chronic care but also the challenges in implementation. The platform simplifies complex administrative processes and assigns rewards to each step of a patient's care journey, such as completing screenings or surveys. By partnering with trusted community organizations, Reciprocity extends its reach into underserved populations, fostering trust and deeper engagement. This model has empowered families to earn meaningful financial rewards while improving their healthcare adherence and outcomes.The company operates as a for-profit enterprise, sustained through client-funded programs with ROI analyses that demonstrate the cost savings of preventive care. At HLTH 2024, Reciprocity Health sought partnerships with health systems, payers, and care providers to accelerate the adoption of value-based care initiatives. Matt emphasizes that Reciprocity acts as a "rising tide," benefiting all stakeholders by reducing costs, improving care delivery, and putting money in patients' pockets. By aligning interests across the healthcare ecosystem, Reciprocity Health is driving meaningful and sustainable change.Tune in for an inspiring conversation with Matthew Swanson to discover how his innovative approach to financial incentives and behavioral health is transforming lives and redefining patient engagement in Medicaid and Medicare!

Welcome baaaaaack to episode 104 of the YGBSP!!! Two years of yapping

In the 17th episode of "Are We All Clear? Facilitating Security Clearances," host Molly O'Casey is joined by Antonia Tzinova, the head of Holland & Knight's Committee on Foreign Investment in the United States (CFIUS) and Industrial Security Team, to identify and analyze the many government entities that play a part in regulating mergers and acquisitions (M&A) that raise national security concerns. In addition to Foreign Ownership, Control or Influence (FOCI) mitigation and CFIUS review, Ms. O'Casey and Ms. Tzinova discuss the rules and responsibilities related to the Directorate of Defense Trade Controls (DDTC), Hart-Scott-Rodino Act (HSR) and Bureau of Economic Analysis (BEA). Both attorneys stress the importance of accurate and timely filings to avoid potential consequences such as loss of export privileges and financial penalties. Adherence to these procedures will protect businesses and enhance national security. Although this field is undoubtedly complex, their concluding advice for companies navigating these regulatory landscapes is simple: "Get help, get it early."

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Section 1: Introduction (0:00 - 5:30) Dr. Valentin Fuster introduces a special issue on Prevention, covering societal and individual prevention aspects and key cardiovascular risk factors. He highlights issues like medication adherence, obesity, and the need for better education and healthcare systems. Section 2: Prevention in Society (5:30 - 35:30) Adherence to Medications The PURE trial shows low medication adherence (31% at follow-up) across 17 countries, despite technological advancements in diagnostics. Barriers include low health literacy and inadequate healthcare systems. Social Determinants of Health Social deprivation leads to worse cardiovascular outcomes, especially among sexual minorities in the U.S. The editorial calls for more equitable healthcare access and anti-stigma efforts. Environmental Factors: Aircraft Noise Higher aircraft noise exposure is linked to worse heart health, urging noise reduction policies for vulnerable populations. Section 3: Prevention in Individuals (35:30 - 55:30) Sedentary Behavior Even with exercise, high sedentary time (over 10.6 hours a day) increases cardiovascular risk. Reducing sedentary time can significantly lower heart disease risk. Intensive Lifestyle Interventions for Diabetes Weight loss and lifestyle changes improve cardiac biomarkers and reduce cardiovascular risk in type 2 diabetes patients. Section 4: Risk Factor Impacts (55:30 - 1:10:00) Hyperlipidemia & Obesity Hyperlipidemia and obesity management, including medications like semaglutide, play key roles in preventing cardiovascular disease. The 2024 ESC hypertension guidelines are also crucial in risk reduction.

Michael Demurjian is Chairman and CEO of Aspargo Labs, a drug development company focused on improving drug delivery through suspension-based formulation and smart device technology. Traditional pill-based drug delivery has significant limitations, with poor absorption rates and difficulties swallowing for many patients. The company's initial focus is on an oral spray formulation of sildenafil to treat erectile dysfunction that has shown rapid absorption. Suspension technology can be applied to reformulate many prescription and over-the-counter drugs to improve drug delivery, adherence, the onset of action, and user experience. Michael explains, "Here at Aspargo we have a proprietary technology, both in the suspension and in how we coat it, so that we can mask the taste of the drug itself. And so I know you're going to probably go down the path of our first drug to market, and I'll answer the next question, but masking is key because there are two things that happen with the masking. One is you make it more of a pleasant experience. People are more willing to adhere and comply than administering the drugs. If you don't, people are going to say, my goodness, that tasted horrible, and I'm not going to do that again. Or they're going to be resistant in particular children, they won't do it."  "Well, 30 years in the drug development business, and I will tell you, you bring an ED product to market where you're showing a five-minute absorption time, it captures a lot of people's attention. So we've been very well received. Our first drug to market is an oral spray, sildenafil, which is the active ingredient in Viagra. And what we've shown is a five-minute absorption time. So, it has a lovely peppermint flavor. Now, here's the key there. Sildenafil is extremely bitter. It's one of the top 20 most bitter drugs that is manufactured. Our taste is peppermint. Through the proprietary technology that we have, we've successfully bonded the flavor agents right to the molecule without damaging it. I'll tell you, it's an interesting experience. Typically, it's the medical community. But when you're looking at a drug like Sildenafil, it's a consumer experience as well." "You have to remind yourself the efficiency of absorption is critical. We look at patients, particularly in oncology, where we know that if they miss a dose of a medicine, cancers rapidly reproduce. So, missing one dose can set a patient back. What we look at and focus on is two things. One is our device to remind patients to dose their medicine. And if they forget that their physician, the physician assistant, or the office manager can intervene and text or call them saying your device just said you didn't dose. That's key." #AspargoLabs #DrugDelivery #ED #ErectileDysfunction #Sildenafil #DrugAdherence #MedTech aspargolabs.com Listen to the podcast here

Michael Demurjian is Chairman and CEO of Aspargo Labs, a drug development company focused on improving drug delivery through suspension-based formulation and smart device technology. Traditional pill-based drug delivery has significant limitations, with poor absorption rates and difficulties swallowing for many patients. The company's initial focus is on an oral spray formulation of sildenafil to treat erectile dysfunction that has shown rapid absorption. Suspension technology can be applied to reformulate many prescription and over-the-counter drugs to improve drug delivery, adherence, the onset of action, and user experience. Michael explains, "Here at Aspargo we have a proprietary technology, both in the suspension and in how we coat it, so that we can mask the taste of the drug itself. And so I know you're going to probably go down the path of our first drug to market, and I'll answer the next question, but masking is key because there are two things that happen with the masking. One is you make it more of a pleasant experience. People are more willing to adhere and comply than administering the drugs. If you don't, people are going to say, my goodness, that tasted horrible, and I'm not going to do that again. Or they're going to be resistant in particular children, they won't do it."  "Well, 30 years in the drug development business, and I will tell you, you bring an ED product to market where you're showing a five-minute absorption time, it captures a lot of people's attention. So we've been very well received. Our first drug to market is an oral spray, sildenafil, which is the active ingredient in Viagra. And what we've shown is a five-minute absorption time. So, it has a lovely peppermint flavor. Now, here's the key there. Sildenafil is extremely bitter. It's one of the top 20 most bitter drugs that is manufactured. Our taste is peppermint. Through the proprietary technology that we have, we've successfully bonded the flavor agents right to the molecule without damaging it. I'll tell you, it's an interesting experience. Typically, it's the medical community. But when you're looking at a drug like Sildenafil, it's a consumer experience as well." "You have to remind yourself the efficiency of absorption is critical. We look at patients, particularly in oncology, where we know that if they miss a dose of a medicine, cancers rapidly reproduce. So, missing one dose can set a patient back. What we look at and focus on is two things. One is our device to remind patients to dose their medicine. And if they forget that their physician, the physician assistant, or the office manager can intervene and text or call them saying your device just said you didn't dose. That's key." #AspargoLabs #DrugDelivery #ED #ErectileDysfunction #Sildenafil #DrugAdherence #MedTech aspargolabs.com Download the transcript here

Send us a textArtificial intelligence is destined to play a big role in the pharmaceutical industry in 2025.With this rapid growth, what specific changes can we expect in patient support and pharmaceutical marketing?And how will that impact healthcare costs and patient experience?In this episode of the HealthBiz Podcast, guest William Grambley, CEO of AllazoHealth, discusses how artificial intelligence and patient-level data can lower operating costs, improve medication adherence, and create tailored solutions for patients at every stage of their journey.TOPICS(0:23) Intro(1:02) Background on William Grambley(2:34) How Naval Service Shaped William Grambley(3:23) The Role of Experience and Work History(6:38) What Brought William to AllazoHealth(9:05) Understanding Compliance, Persistence, and Adherence(10:36) Examining Low Levels of Adherence(12:28) How Issues with Medication Adherence Have Changed Over Time(15:00) Distinguishing Between Adherence and Therapy Initiation(17:32) The Importance of Personalization(20:35) The Future of Pharma and AI in 2025(25:02) Dynamic Change and Personalization(27:36) GLP-1s and Adherence(30:30) Book Recommendations from William Grambley

Dr. Salim Dib emphasizes that enhancing adherence to positive airway pressure (PAP) therapy in sleep apnea patients is essential for achieving optimal benefits.

Non-Adherence

In this episode, Tzu-Hao (Howard) Lee, MD; Tatyana Kushner, MD, MSCE; and patient advocate Andrew Reynolds discuss hepatitis C virus (HCV) care in men who have sex with men and pregnant people, including:HCV disease burden in the United StatesScreening recommendations Strategies to overcome barriers to HCV screeningTreatment recommendations, including simplified treatment guidance and considerations for pregnant peopleStrategies to improve treatment uptakePresenters:Tzu-Hao (Howard) Lee, MDAssistant ProfessorSection of Gastroenterology and Hepatology, Department of MedicineDivision of Abdominal Transplant, Department of SurgeryBaylor College of MedicineHouston, TexasTatyana Kushner, MD, MSCEAssociate ProfessorDivision of Gastroenterology/HepatologyDepartment of Obstetrics & GynecologyWeill Cornell MedicineNew York, New YorkAndrew ReynoldsDirector, Health of People Who Use DrugsSan Francisco AIDS FoundationSan Francisco, CaliforniaTo access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Link to full program:https://bit.ly/4j973TNDownloadable slides: https://bit.ly/4gXuBcu

Learn the skills to Regulate your Emotions, join the membership: https://courses.therapyinanutshell.com/membership Can the Keto Diet Revolutionize Mental Health Treatment? Emerging research suggests that metabolic treatments like the ketogenic diet could be groundbreaking for mental health. Traditionally used to manage epilepsy, the keto diet—a high-fat, low-carb, moderate-protein approach—induces ketosis, a state where the body uses fat as its primary energy source. This metabolic shift may improve brain function by stabilizing neuronal activity, reducing inflammation, and enhancing mitochondrial health. These benefits are now being explored for severe mental health conditions like bipolar disorder, schizophrenia, and depression. One study found that 43% of patients with severe psychiatric disorders achieved remission on a medical ketogenic diet, and all participants experienced symptom improvement. Stories like Lauren Kennedy West's—who used keto to manage her schizoaffective disorder and eventually stopped psychiatric medications—highlight its transformative potential. Harvard psychiatrist Dr. Chris Palmer theorizes that mental illnesses are rooted in metabolic dysfunction. By addressing underlying metabolic issues, interventions like keto, intermittent fasting, and exercise could revolutionize treatment. However, while the results are promising, challenges remain. Adherence to keto can be difficult, and long-term effects on gut health and nutrient balance require further research. Metabolic treatments offer hope and a fresh perspective for those seeking alternatives to traditional mental health approaches. Always consult a professional before trying such interventions.  Looking for affordable online counseling? My sponsor, BetterHelp, connects you to a licensed professional from the comfort of your own home. Try it now for 10% off your first month: https://betterhelp.com/therapyinanutshell Learn more in one of my in-depth mental health courses: https://courses.therapyinanutshell.com Support my mission on Patreon: https://www.patreon.com/therapyinanutshell Sign up for my newsletter: https://www.therapyinanutshell.com Check out my favorite self-help books: https://kit.co/TherapyinaNutshell/best-self-help-books  Therapy in a Nutshell and the information provided by Emma McAdam are solely intended for informational and entertainment purposes and are not a substitute for advice, diagnosis, or treatment regarding medical or mental health conditions. Although Emma McAdam is a licensed marriage and family therapist, the views expressed on this site or any related content should not be taken for medical or psychiatric advice. Always consult your physician before making any decisions related to your physical or mental health. In therapy I use a combination of Acceptance and Commitment Therapy, Systems Theory, positive psychology, and a bio-psycho-social approach to treating mental illness and other challenges we all face in life. The ideas from my videos are frequently adapted from multiple sources. Many of them come from Acceptance and Commitment Therapy, especially the work of Steven Hayes, Jason Luoma, and Russ Harris. The sections on stress and the mind-body connection derive from the work of Stephen Porges (the Polyvagal theory), Peter Levine (Somatic Experiencing) Francine Shapiro (EMDR), and Bessel Van Der Kolk. I also rely heavily on the work of the Arbinger Institute for my overall understanding of our ability to choose our life's direction. And deeper than all of that, the Gospel of Jesus Christ orients my personal worldview and sense of security, peace, hope, and love https://www.churchofjesuschrist.org/comeuntochrist/believe If you are in crisis, please contact the National Suicide Prevention Hotline at https://suicidepreventionlifeline.org or 1-800-273-TALK (8255) or your local emergency services. Copyright Therapy in a Nutshell, LLC

In this episode of the Play Therapy Podcast, I answer three questions from Mai in Bahrain, a mental health counselor in training. Mai asks about integrating brief interventions within the child-centered play therapy (CCPT) framework, handling power struggles in the playroom, and pursuing play therapy certification as an international practitioner.  I explain why maintaining strict adherence to the non-directive nature of CCPT is crucial and suggest involving parents through psychoeducation rather than introducing interventions during sessions. I also outline strategies for navigating power struggles, emphasizing the importance of understanding the child's intent—whether it's a need for control, learned helplessness, or collaboration—and responding accordingly. Lastly, I provide insights on certification options for international practitioners, including how they can pursue training through my programs while navigating their country's unique regulations. This episode is packed with practical advice for therapists around the globe! Play Therapy Podcast Livestream!  Jan. 3rd, 2025 @ 2pm EST Register here (100 attendee limit): https://playtherapypodcast.com/livestream Sign up for my exclusive newsletter at playtherapynow.com. Stay ahead with the latest CCPT CEU courses, personalized coaching opportunities and other opportunities you need to thrive in your CCPT practice! If you would like to ask me questions directly, check out www.ccptcollective.com, where I host two weekly Zoom calls filled with advanced CCPT case studies and session reviews, as well as member Q&A. You can take advantage of the two-week free trial to see if the CCPT Collective is right for you. Ask Me Questions: Call ‪(813) 812-5525‬, or email: brenna@thekidcounselor.com Brenna's CCPT Hub: https://www.playtherapynow.com CCPT Collective (online community exclusively for CCPTs): https://www.ccptcollective.com Podcast HQ: https://www.playtherapypodcast.com APT Approved Play Therapy CE courses: https://childcenteredtraining.com Twitter: @thekidcounselor https://twitter.com/thekidcounselor Facebook: https://facebook.com/playtherapypodcast Common References: Cochran, N., Nordling, W., & Cochran, J. (2010). Child-Centered Play Therapy (1st ed.). Wiley. VanFleet, R., Sywulak, A. E., & Sniscak, C. C. (2010). Child-centered play therapy. Guilford Press. Landreth, G.L. (2023). Play Therapy: The Art of the Relationship (4th ed.). Routledge. Bratton, S. C., Landreth, G. L., Kellam, T., & Blackard, S. R. (2006). Child parent relationship therapy (CPRT) treatment manual: A 10-session filial therapy model for training parents. Routledge/Taylor & Francis Group. Benedict, Helen. Themes in Play Therapy. Used with permission to Heartland Play Therapy Institute.

In this episode of the Play Therapy Podcast, I dive into the importance of theoretical adherence in child-centered play therapy (CCPT). As we wrap up 2024 and look forward to 2025, I reflect on the foundational role adherence plays in ensuring effective therapy. I discuss why sticking to one theoretical model—not just CCPT but any model—is essential for achieving consistent results, preserving the therapeutic relationship, and maintaining ethical practice. When we deviate or adopt an eclectic approach, we risk losing the evidence-based validation that gives therapy its impact and clarity. I also share how adhering fully to CCPT eliminates frustration for therapists, simplifies the process, and strengthens outcomes for children. Whether you're new to CCPT or have been practicing for years, this episode serves as both encouragement and a challenge to commit fully to the model, trusting its principles and framework for the sake of your clients and your professional growth. Play Therapy Podcast Livestream!  Jan. 3rd, 2025 @ 2pm EST Register here (100 attendee limit): https://playtherapypodcast.com/livestream Sign up for my exclusive newsletter at playtherapynow.com. Stay ahead with the latest CCPT CEU courses, personalized coaching opportunities and other opportunities you need to thrive in your CCPT practice! If you would like to ask me questions directly, check out www.ccptcollective.com, where I host two weekly Zoom calls filled with advanced CCPT case studies and session reviews, as well as member Q&A. You can take advantage of the two-week free trial to see if the CCPT Collective is right for you. Ask Me Questions: Call ‪(813) 812-5525‬, or email: brenna@thekidcounselor.com Brenna's CCPT Hub: https://www.playtherapynow.com CCPT Collective (online community exclusively for CCPTs): https://www.ccptcollective.com Podcast HQ: https://www.playtherapypodcast.com APT Approved Play Therapy CE courses: https://childcenteredtraining.com Twitter: @thekidcounselor https://twitter.com/thekidcounselor Facebook: https://facebook.com/playtherapypodcast Common References: Cochran, N., Nordling, W., & Cochran, J. (2010). Child-Centered Play Therapy (1st ed.). Wiley. VanFleet, R., Sywulak, A. E., & Sniscak, C. C. (2010). Child-centered play therapy. Guilford Press. Landreth, G.L. (2023). Play Therapy: The Art of the Relationship (4th ed.). Routledge. Bratton, S. C., Landreth, G. L., Kellam, T., & Blackard, S. R. (2006). Child parent relationship therapy (CPRT) treatment manual: A 10-session filial therapy model for training parents. Routledge/Taylor & Francis Group. Benedict, Helen. Themes in Play Therapy. Used with permission to Heartland Play Therapy Institute.

Dr. Bob Kay from CHLA joins the show to discuss his recent research on access to hip reconstruction surgery for neuromuscular patients in the Los Angeles area. The Lightning Round discussion spans numerous hip topics including hip preservation surgery and Perthes as well as recent studies on MPFL reconstruction. Your hosts are Carter Clement from Children's Hospital of New Orleans, Josh Holt from Iowa, and Tyler McDonald from University of South Alabama. Music by A. A. Aalto.   References: X-Ray Adventures: https://www.amazon.com/X-ray-Adventures-Carter-Clement/dp/B0D9C5CRTF 1) Timely Hip Surgery Access in Children with Cerebral Palsy: Unaffected by Social Disadvantage at a Large Urban Safety Net Hospital. Wimmer et al. JPO, Oct 2024. PMID: 39350583. 2) Exploring the Experiences and Expectations of Adolescent Females Undergoing Periacetabular Osteotomy. Luck et al. JPO, Aug 2024. PMID: 39171434. 3) Risk of Venous Thromboembolism in Adolescents Undergoing Pelvic Osteotomy: Insights From a Propensity-matched Retrospective Cohort Study. Mittal et al. JPO, Oct 2024. PMID: 39363394. 4) Prevalence and Risk Factors for Stiffness Following Open Reduction for Developmental Dysplasia of the Hip. Desai et al. JPO, Nov-Dec 2024. PMID: 39021118. 5) Adherence to Wide-Abduction Brace Treatment is Associated With Improved Hip Abduction and Radiographic Outcomes in Legg-Calvé-Perthes Disease. Prasadh et al. JPO, Nov-Dec 2024. PMID: 39187945. 6) Medial Patellofemoral Ligament Reconstruction in Adolescents: What Parents Care About. Culpepper et al. JPO, Aug 2024. PMID: 39171383. 7) Medial Patellofemoral Ligament Reconstruction Improves Patella Alta. Yang et al. JPO, Sep 2024. PMID: 39279747.